Sage Journals: Discover world-class research

Abstract

Welcome to the inaugural column of RxLegal. This quarterly column will discuss a wide range of legal topics of interest to the pharmacy community. In this installment, the impact of potential federal funding for academic detailing through the Independent Drug Education and Outreach Act (IDEA) on the practice of pharmacy will be reviewed.

Get full access to this article

View all access options for this article.

References

RxFacts.org. The Independent Drug Information Service. http://www.rxfacts.org/. Accessed August 10, 2010.

PEW Prescription Project. Academic detailing: evidence-based prescribing information. http://www.prescriptionproject.org/tools/fact_sheets/files/0007.pdf. Accessed August 10, 2010.

Avorn

Statement to the Senate Committee on Aging. http://aging.senate.gov/events/hr190ja.pdf. Accessed August 10, 2010.

Avorn

, Soumerai

S.B.

Improving drug-therapy decisions through educational outreach. N Engl J Med. 1983; 308(24): 1457–1463.

Stafford

R.S.

, Bartholomew

L.K.

, Cushman

W.C.

. Impact of the ALLHAT/JNC7 Dissemination Project on thiazide-type diuretic use. Arch Intern Med. 2010; 170(10): 851–858.

PEW Prescription Project. Cost-effectiveness of prescriber education (“academic detailing”) programs. http://www.prescriptionproject.org/tools/initiatives_reports/files/Final-AcademicDetailing_CostEffectiveness_Analysis_3-12-2008_CB.pdf. Accessed August 10, 2010.

Independent Drug Education and Outreach Act of 2009. H.R. 1859; S. 767. 111th Congress. 1st Session. 2009.

Academic Detailing and the IDEA Act

Abstract

Get full access to this article

References